M
icrovascular disease underlies many chronic diseases, and yet the requirements for microvascular health are poorly understood. [1] [2] [3] Functional blood vessels permit nutrition and oxygen delivery, and adaptive responses to conditions with reduced oxygen availability, or hypoxia, are primarily mediated by hypoxia-inducible factors (HIFs). 4 HIFs include the oxygen-sensitive α subunits (HIF-1α or HIF-2α) and the constitutively expressed β subunit (HIF-1β). Both HIF-1α and HIF-2α are regulated mainly at the posttranslational level. Under normoxic conditions, they are degraded through a proteasome-mediated mechanism, in which specific proline residues are hydroxylated by the prolyl hydroxylase domain proteins 1 to 3, followed by von Hippel-Lindau protein-mediated ubiquitination and degradation. When oxygen levels are low, prolyl hydroxylase domain activity is inhibited, and HIF-α subunits are stabilized, translocate to the nucleus, dimerize with HIF-1β, and bind to hypoxia response elements to activate target gene transcription. 4 Despite that HIF-1α and HIF-2α share highly conserved structural features and regulate overlapping batteries of target genes, mounting evidence suggests that they also play remarkably different functional roles in specific cellular contexts through regulating distinct target gene expression. 4 The function of HIF in microvascular homeostasis requires a fuller understanding.
There have been intriguing clues implicating a physiological role for HIF isoforms in the lung circulation. Hif-1α and Hif-2α heterozygous mice are protected from hypoxia-induced pulmonary hypertension (PH). 5, 6 Alk1-Cre-mediated endothelial cell (EC) HIF-2α deletion also prevented hypoxia-induced PH in mice. 7 Stabilizing HIF-2α in endothelial and hematopoietic cells promotes severe PH. 8 Similarly, HIF-2α stabilization through vascular endothelial (VE)-cadherin-Cre-mediated prolyl hydroxylase domain 2 deletion promotes PH. 9 Population genetic studies identified an evolutionary selection of HIF-2α variants in Tibetans residing at high altitudes. 10 Airway microvasculature attenuation and hypoxemia are common in chronic obstructive pulmonary disease and are possibly both a cause and consequence of decreased lung HIF-1α and HIF-2α expression. [11] [12] [13] Lung transplantation is similarly affected by microvascular attrition in association with chronic rejection.
14 In mice, overexpressing HIF-1α or upregulating both HIF isoforms during acute rejection protects the airway microvasculature and limits chronic rejection. 15, 16 These cumulative findings show that the role of HIF is context-specific, both pathology-driving as well as diseaselimiting, and suggest that the circulatory bed may be a physiologically relevant source for HIF isoforms.
To further evaluate this possibility, we assessed the role of endothelially derived HIFα in the airways of transgenic mice and considered the contributions of intimal HIF isoforms on alloimmune rejection in orthotopic tracheal transplantation. The trachea is an ideal location for examining airway blood vessel changes because the microvasculature is arranged in a single plane, which facilitates the comparison between experimental groups. 17 We used an inducible loss-or gain-of-function genetic approach to delete or overexpress Hif-1α or Hif-2α in endothelial lineage cells using the VE-cadherin-CreERT2, an EC-specific tamoxifen-inducible Cre system. 18 We demonstrate that EC-expressed HIF-2α, but not HIF-1α, plays an essential role in maintaining the structure and function of airway microvessels. HIF-2α maintains vascular integrity through angiopoietin 1 (ANGPT1)/TIE2 signaling and promotes transplant health by diminishing tissue inflammation and augmenting transplant microvascular perfusion. The cumulative findings demonstrate that the production of HIF-2α by vascular ECs elicits vital homeostatic cues that preserve airway health.
Clinical Perspective
What Is New?
• In adult mice, endothelial cell (EC) expression of hypoxia-inducible factor (HIF)-2α but not HIF-1α maintains normal airway microvascular circulation and anatomic integrity.
• HIF-2α preserves microvascular integrity by inducing endothelial TIE2 expression and sustaining tonic angiopoietin 1-induced TIE2 activity.
• HIF-2α-mediated TIE2 signaling maintains EC vitality and induces Notch downstream pathways, which in turn promote mural cell coverage.
• Endothelial HIF-2α deficiency accelerates and overexpression prevents the loss of a functional microvasculature in an orthotopic tracheal transplantation model; heightened EC HIF-2α improves transplant health by promoting microvessel integrity and limiting tissue inflammation.
What Are the Clinical Implications?
• HIF-2α signaling is implicated in pulmonary hypertension and chronic obstructive pulmonary diseases, but the role of endothelial HIF-2α in pulmonary vascular homeostasis is unknown.
• Our study indicates that EC HIF-2α expression is required for the maintenance of airway microvasculature, and therapies that suppress HIF-2α activity may cause deleterious effects in pulmonary airways.
• In tracheal transplant allografts undergoing vascular rejection, HIF-2α functions as a factor that promotes EC survival and vascular integrity; this latter observation may provide a novel therapeutic focus for inflammatory diseases characterized by circulatory compromise. 
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METHODS
An expanded Methods section is available in the online-only Data Supplement. All materials, datasets, and protocols used in this study will be made available to investigators on request. Requests for resources and reagents should be directed to and will be fulfilled by the corresponding authors.
Mice
All animal procedures were approved by Stanford's Administrative Panel on Laboratory Animal Care and the VA Palo Alto Institutional Animal Care and Utilization Committee. Detailed breeding strategy and animal study design are found in the online-only Data Supplement.
Morphometric Measurements
For pimonidazole and microsphere immunofluorescence quantification, total fluorescence intensity from multiple highpower fields was calculated and averaged. Intensity was then normalized to control (which was set to 1). TIE2, phosphorylated TIE2 (p-TIE2), terminal deoxynucleotidyl transferase dUTP nick end labeling, and activated caspase 3 intensity on CD31 + ECs were calculated as area density (total intensity/ area). The number of infiltrated immune cells in the wild-type or Hif-2α ECOE (EC-specific Hif-2α overexpressed) transplants was quantified based on ≥6 high-power fields per sample.
Systemic or Local Adenoviral Vector Administration for Preventing or Reversing Hif-2α EC-Specific Knockout Caused Airway Attenuation
For Angpt1, Angpt2, or Vegfa overexpression experiments, adenoviral vectors expressing Angpt1, Angpt2, or Vegfa (Vector Biolabs) were intravenously injected. The concentration of each type of virus used was 1×10 9 plaque-forming unit as established by a prior study.
19 AdDll4 (Vector Biolabs) was administered locally into or around the trachea using 4×10 10 plaque-forming unit. AdLacZ was used as a vector control. A detailed treatment timeline is shown in Table I in the online-only Data Supplement.
Statistical Analysis
GraphPad Prism version 6.0 was used for statistical analysis. Differences between 2 groups at a single time point were compared using the Mann-Whitney test or Student's t test. For comparisons between multiple experimental groups at a single time point, the Kruskal-Wallis test followed by Dunn's multiple comparisons test for post hoc analyses or 1-way ANOVA followed by Tukey's post hoc test were used. All analyses were considered statistically significant at P<0.05.
A detailed description of tracheal transplantation (summary of transplant donor and recipient combinations are shown in Table II in the online-only Data Supplement), microvascular perfusion and leakage analysis, immunohistochemistry, tracheal whole mount immunofluorescence, Picrosirius red staining, hypoxia assessment and blood perfusion measurement, scanning electron microscope studies, real-time reverse transcription quantitative polymerase chain reaction (primer pairs used are provided in Table III in  the online-only Data Supplement) , flow cytometry analysis, microarray analysis, and Western blotting are found in the online-only Data Supplement.
RESULTS
Endothelial-Specific Hif-2α Deletion in Adult Mice Causes Airway Microvascular Attenuation
Mice with EC-specific knockout (ECKO) of Hif-1α or Hif-2α (Hif-1α ECKO and Hif-2α ECKO , respectively) were evaluated. The tdTomato expression pattern indicated that Cre induced specific and efficient gene recombination in ECs ( Figure 1A) . The HIF gene knockout or overexpression efficiency in ECs was validated by polymerase chain reaction analysis of target genes and immunofluorescence staining with quantification ( Figure I in the online-only Data Supplement). Under normal physiological conditions, EC-specific Hif-1α or Hif-2α overexpression (Hif-1α ECOE or Hif-2α ECOE ) did not cause notable functional changes in tracheal microvasculature determined by the fluorescein isothiocyanate-conjugated lectin assay, microsphere leakiness, and perfusion. The latter test is performed through direct serial fiberoptic measurements of the outer tracheal airway surface and produces readings of blood perfusion units (BPUs), which correlate with blood cell perfusion in the microvasculature ( Figure  II in the online-only Data Supplement). Similarly, endothelial Hif-1α deficiency did not induce significant changes in airway fluorescein isothiocyanate-lectin perfusion, BPU measurements, and tissue hypoxia status measured by the hypoxyprobe, pimonidazole ( Figure 1A through 1D) . However, tracheas of Hif-2α ECKO mice demonstrated progressive vascular attenuation and declining perfusion, microvessel structural abnormalities, and tissue hypoxia at day 21 after gene deletion ( Figure 1A through 1D and Figure  III in the online-only Data Supplement). Intercartilaginous areas of these tracheas displayed vessels with attenuated vascular structures ( Figure 1A ), including abnormally arranged ECs with no perfusion (c1); fluorescein isothiocyanate-lectin-perfused structures with no intimal lining (c2), which may represent perfusion through a basement ghost as described 20 ; areas without perfusion or intimal lining (c3); and ECs with excessive filopodia protrusions (white arrows). By contrast, fluorescein isothiocyanate-lectin perfusion of vascular beds of the retina, heart, and kidney revealed no obvious vascular anomalies in the same Hif-2α-deficient mice ( Figure IV in the online-only Data Supplement), suggesting that the lung vascular bed uniquely requires endothelial HIF-2α for its maintenance. We have previously shown that rejection of transplant airway microvessels is tightly associated with airway epithelial denudation and subepithelial fibrosis. 15 We hypothesized that microvascular damage in Hif-2α ECKO mice, even in the absence of alloimmune-mediated injury, would similarly result in airway pathology. An ultrastructural evaluation of Hif-2α ECKO tracheas performed on day 21 revealed epithelial pathology, particularly in those areas adjacent to tracheal cartilage (Figure 2A and 2B) . A defective epithelial lining, remarkable for dystrophic club cells and ciliated cell flattening, was observed in airways of ≈100 μm diameter ( Figure 2C ). To investigate changes in gene expression, we performed a microarray analysis of day 28 Hif-2α ECKO tracheas and found that the ECKO airways expressed significantly higher levels of extracellular matrix proteins, including Col1a1, Col8a1, Col9a1, Col11a1, and Fibrillin 2 ( Figure 2D) ; real-time quantitative polymerase chain reaction analysis confirmed the microarray data ( Figure 2E) . Additionally, the downregulation of epithelial cell markers such as Crisp3, Cxcl15, Adam8, Dnah3, Dnah5, Dnah9, and Dnah12 corroborated the findings of epithelial cell loss (Table IV in the online-only Data Supplement). Consistent with the gene expression data, there was also a substantial increase in subepithelial collagen, as evinced by Picrosirius red staining ( Figure 2F and 2G) . In summary, microvascular disruption and interrupted blood flow were associated with endothelial Hif-2α deletion and correlated with airway epithelial compromise and regional fibrosis. 
Endothelial-Specific
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mice exhibited greater extravasation ( Figure 3A and 3B). Scanning electron microscope images illustrating the ultrastructure of the endothelial apical surface of the Hif-2α ECKO trachea revealed remarkable intercellular gaps ( Figure 3C ). Adult Hif-2α ECKO mice also displayed disrupted EC junctions of the lung capillaries ( Figure VA in the online-only Data Supplement) with increased permeability ( Figure VB and VC in the online-only Data Supplement). To address the possibility that EC loss is caused by apoptosis, we examined airways at day 21 and found that Hif-2α
ECKO tracheas exhibited greater vascular terminal deoxynucleotidyl transferase dUTP nick end labeling staining ( Figure 3D and 3E). Because EC apoptosis and permeability are correlated with pericyte loss, 21, 22 we investigated pericyte coverage in transgenic animals. We found that the control tracheal microvessels were well enveloped with pericytes, identified by a proteoglycan NG-2 or Desmin immunofluorescence. By contrast,
Hif-2α
ECKO microvasculature demonstrated incomplete pericyte coverage ( Figure 3F through 3I). Perivascular collagen IV was also disorganized, and its level was significantly lower in Hif-2α ECKO vessels ( Figure 3J and 3K), indicating a disrupted pericyte-EC interaction and abnormal vascular structure. Endothelial expression of VEcadherin is lower in Hif-2α ECKO microvessels (Figure VI in the online-only Data Supplement), which is consistent with a previous study showing that HIF-2α may stabilize EC VE-cadherin. 23 Collectively, these data demonstrated that EC-specific Hif-2α deletion in adult mice resulted in pericytes loss, EC junction disruption, and increased permeability in the airway microvasculature.
Endothelial-Specific Hif-2α Deletion Reduces Airway EC TIE2 and Tissue ANGPT1 Expression
Because HIF-2α is a key transcription factor that regulates various angiogenesis-related genes, 4 we A, Representative scanning electron microscope images of the inner surface of wild type (WT) and Hif-2α ECKO tracheas (n=3). CA outlined by the white dashed lines was reimaged using higher magnification to identify epithelial cell types. Club cells and ciliated epithelial cells were labeled (n=3). B, Representative cross-sectional images of epithelium scanning electron microscope (n=3). C, Representative scanning electron microscope images of the epithelial layers of airways ≈100 µm in diameter. Flattening of club cells (green arrow) and cilia (red arrow) was highlighted in the Hif-2α ECKO samples (n=3). D, Genes upregulated in Hif-2α ECKO airways were identified by microarray analysis (d28 Hif-2α ECKO versus WT tracheas). Gene expression in fold change was normalized to that of the WT (n=3). E, RT-qPCR confirmation of the microarray data (n=5). F and G, Collagen deposition assessed by Picrosirius red staining of the WT or d28 Hif-2α ECKO tracheas (F) and the quantification (G) (n=5). WTs are littermate controls. E and G, Data are presented as mean±standard error of the mean; *P<0.05; **P<0.01; by the Mann-Whitney test. Table V in the online-only Data Supplement). This analysis used tracheal samples collected on day 7 after Hif-2α deletion because a drop in BPUs was prominent at this time point. Angpt1 is the most significantly downregulated gene after Hif-2α deletion, and ANGPT1/ TIE2 signaling is known to promote pericytes coverage and prevent vascular leakage. 21, 22 We therefore chose to investigate the cell type-specific protein levels of both ANGPT1 and TIE2 in the trachea. Because pericytes represent the primary source for tissue ANGPT1 production, 22 we sought to determine the ANGPT1 levels in Desmin-positive pericytes in Hif-2α ECKO airway samples. Pericyte-derived ANGPT1 intensity was notably decreased ( Figure 4B and 4C); this observation is consistent with the fact that the Hif-2α ECKO airway microvasculature exhibited decreased pericyte coverage.
TIE2 is the primary receptor for ANGPT1, a factor that mediates capillary stability and is expressed most abundantly in ECs. 21 We found that the TIE2 receptor was significantly decreased in airways at day 7 in Hif-2α ECKO airways ( Figure 4D and 4E). p-TIE2 is also significantly diminished in ECs of these mice, suggesting that the ANGPT1/TIE2 signaling is reduced in the absence of endothelial Hif-2α ( Figure 4F and 4G) . Further, in human pulmonary arterial ECs cultured under hypoxic conditions, we were able to modulate endothelial HIF-2α protein expression by using either adenoviral vector-expressing HIF-2α or lentiviral vector expressing shHIF-2α (Figure VIIA in online-only Data Supplement). HIF-2α overexpression induced TIE2 mRNA expression in pulmonary arterial ECs; conversely, HIF-2α knockdown resulted in reduced transcripts of TIE2 (Fig- 
ANGPT1 Overexpression Prevents Airway Microvascular Attenuation Induced by Endothelial Hif-2α Deletion
To investigate whether dysregulated ANGPT1 and TIE2 expression was the principal defect induced by endothelial Hif-2α deletion, we used adenovirus-mediated gene overexpression to enhance the ANGPT1, AN-GPT2, or VEGFA expression levels. Recombinant adenovirus-expressing mouse Angpt1, Angpt2, or Vegfa ORIGINAL RESEARCH ARTICLE (AdAngpt1, AdAngpt2, or AdVegfa) was administered intravenously to Hif-2α ECKO mice on the same day as the first dose of tamoxifen was injected. Notably, Angpt1 overexpression prevented airway microvascular attenuation, leakage, and BPU drop after Hif-2α deletion ( Figure 5A through 5D) . By contrast, AdAngpt2 and AdVegfa were not effective in preventing the development of vascular abnormality caused by EC Hif-2α deficiency ( Figure 5A through 5D ). In particular, AdAngpt2-treated airway vessels were leaky, with the presence of dilated capillaries ( Figure 5A ). Adenoviral-mediated gene delivery of Angpt1 but not of Angpt2 or Vegfa prevented microsphere leakage in the lung ( Figure IX in the online-only Data Supplement). Additionally, AdAngpt1 treatment starting on day 7, after Hif-2α deletion, was effective in reversing airway microvascular attenuation, permeability increase, and BPU drop ( Figure  X in the online-only Data Supplement). At the cellular level, Angpt1 overexpression prevented EC apoptosis ( Figure 5E and 5F) and NG-2 + pericyte loss ( Figure 5G  and 5H ). These data collectively indicate that ANGPT1/ TIE2 signaling is likely a major dysregulated pathway in Hif-2α ECKO airways.
Diminished Notch Activity in Hif-2α
ECKO
Airways and Pulmonary Arterial ECs With Hif-2α Knockdown Is Restored by Enhanced ANGPT1
Because HIF-2α regulates angiogenesis through Notch activation 24 and ANGPT1/TIE2 signaling induces Notch activity in ECs, 25 we hypothesized that HIF-2α maintains EC health through tonic ANGPT1/TIE2-mediated induction of Notch signaling. To evaluate this possibility, we assessed Notch signaling in Hif-2α ECKO airways in the presence of ANGPT1 treatment. The mRNA expression of a group of Notch downstream genes, including Efnb2, Hes1, Hes5, and Dll4, was downregulated in Hif-2α ECKO tracheas and restored by the AdAngpt1 treatment ( Figure 6A ). This finding suggests that AN-GPT1/TIE2 signaling is involved with the HIF-2α activation of Notch. To further verify the signaling cascade of HIF-2α-ANGPT1/TIE2-Notch in ECs, we used an in vitro pulmonary arterial EC culture system. Luciferase assays show that silencing HIF-2α using lentiviral shRNA reduced CSL×6 (CBF-1/suppressor of hairless/ Lag1) 26 Notch promoter activity, and ANGPT1 restored ECKO tracheas treated with AdLacZ or AdAngpt1. F and H, Quantification of TUNEL (F) (n=6) or NG-2 (H) (n=5) intensity comparing the groups shown in E or G. B through D, F, and H, Data are presented as mean±standard error of the mean; ns, not significant; *P<0.05; **P<0.01; ***P<0.001 by the Kruskal-Wallis test followed by Dunn's multiple comparisons test. Scale bars: 100 μm (A), 20 μm (G), and 10 μm (E). ECKO indicates endothelial cell specific knockout; and ns, not significant.
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the luciferase intensity to the basal level in ECs with HIF-2α knockdown ( Figure 6B ). Further, HIF-2α overexpression using adenoviral vector-expressing HIF-2α induced luciferase activity, whereas the TIE2 inhibitor reduced this activity ( Figure 6B ). Similarly, polymerase chain reaction analysis of EFNB2, HES1, and HES5 expression indicated that HIF-2α deficiency reduced, whereas ANGPT1 restored, their expression in shHIF-2α-treated ECs; the TIE2 inhibitor suppressed adenoviral vector-expressing HIF-2α-induced gene expression ( Figure 6C ). These in vitro studies collectively indicated that HIF-2α regulates Notch signaling in ECs in a TIE2 signaling-dependent manner.
To further confirm the importance of Notch signaling as a mechanism by which HIF-2α preserves airway microvessels, we next explored whether the restoration of 
airways and Hif-2α-deficient pulmonary arterial endothelial cells (PAEC). A, Polymerase chain reaction (PCR) analysis of representative Notch target genes expressed in wild type (WT) and Hif-2α
ECKO airways with or without AdAngpt1 (WT, n=5; Hif-2α ECKO , n=6; Hif-2α ECKO +AdAngpt1, n=4). B, Luciferase activity of PAECs cotransfected with Notch reporter plasmid pG13-11-CSL and pRL-SV40. PAECs were treated with shHIF-2α, AdHIF-2α, recombinant ANGPT1 (50ng/mL), shHIF-2α+ANGPT1, TIE2I (TIE2 inhibitor, 2.5μM), and AdHIF-2α+TIE2I for 72 hours, followed by the reporter assay; shControl and AdControl are vector controls (n=5). C, RT-qPCR analysis of Notch target genes ephrin-B 2 (EFNB2), HES1, and HES5 in PAEC culture treated with shHIF-2α, AdHIF-2α, AdHIF-2α+TIE2I, ANGPT1 (50 ng/mL), or shHIF-2α+ANGPT1 for 72 hours (n=5). D, Representative images of fluorescein isothiocyanate (FITC)-lectin perfusion (green) and microsphere leakage (red) study of WT and Hif-2α ECKO mice with or without Ad delta-like ligand 4 (AdDll4) treatment. Adenoviral particles were locally administered to the trachea on the first day of tamoxifen administration. Samples were harvested at day 21 after Hif-2α deletion. LacZ adenovirus was used as the adenoviral vector control (n=8). E, Blood perfusion unit (BPU) measurement of the WT and Hif-2α ECKO airways with or without AdDll4 treatment (n=7). F and G, Quantification of perfused area (F) (n=8) and microsphere leakage (G) (n=8) comparing the groups in D. H, Representative immunofluorescence staining of NG-2 (green) and CD31 (red) in Hif-2α ECKO tracheas treated with AdLacZ or AdDll4. I, Quantification of NG-2 intensity comparing the groups shown in H (n=6). J, HIF-2α maintains airway microvascular integrity. Normal airway microvasculature displays a quiescent EC layer and intact pericyte coverage. HIF-2α maintains the normal vasculature by sustaining ANGPT1/TIE2 signaling. Pericyte-derived ANGPT1 activates HIF-2α-regulated TIE2, which promotes cell survival and activates the Notch target genes and preserves pericyte coverage and vessel integrity. EC HIF-2α deficiency leads to loss of pericyte coverage and EC death or appearance of excessive filopodia protrusions. Diminished TIE2 expression caused by HIF-2α deficiency leads to decreased ANGPT1/TIE2 signaling, which through increasing cell apoptosis or reducing Notch signaling causes pericyte loss. Decreased pericyte numbers lead to lower ANGPT1 production and further reduce ANGPT1/TIE2 signaling. A through C, E through G, and I, Data are presented as mean±standard error of the mean; *P<0.05; **P<0.01; by the Kruskal-Wallis test followed by Dunn's multiple comparisons test (A and E through G), by the Mann-Whitney test (I), or by one-way ANOVA followed by Tukey's multicomparisons test (B and C) (C: significance compared to control). PC, pericytes. Scale bars: 100 μm (D) and 20 μm (H). ECKO indicates endothelial cell specific knockout; ns, not significant; and PC, pericyte. ECKO tracheas ( Figure 6D through 6G). Consistent with limiting microsphere leakage observed in this experimental group, administration of adenovirus expressing the Notch ligand Delta-like 4 also improved NG-2 + pericyte coverage ( Figure 6H and 6I) . ANGPT1-induction of Notch signaling is dependent on gene transcription mediated by β-catenin-bound encoding recombination signal binding protein for immunoglobulin kappa J region (RBPJ), the transcriptional activator of Notch signaling. 25 Consequently, we hypothesized that the maintenance of airway microvessels through HIF-2α-ANGPT1/TIE2 signaling requires endothelial RBPJ. EC-specific Rbpj knockout (Rbpj ECKO ) airway microvessels displayed decreased perfusion, increased permeability, and diminished mural cell coverage (Figures XI . In summary, our findings suggest that airway microvascular health requires tonic HIF-2α activation of ANGPT1/TIE2 signaling, which sustains Notch activity, promotes endothelial survival, and preserves pericyte coverage ( Figure 6J ).
Circulation
Endothelial Hif-2α But Not Hif-1α Deficiency Accelerates Microvascular Loss After Airway Transplantation
To study the role of HIF isoforms in a disease model characterized by hypoxia and regional ischemia, we evaluated endothelial HIF transgenic tracheas transplanted as fully functional allografts. Here, mice breathe through their transplants as the donor and recipient airway microcirculatory systems eventually fuse 4 days after transplantation. 15, 27 In the absence of immunosuppression, major histocompatibility complexincompatible transplants undergo rejection, and the donor microcirculatory bed is severely damaged by day 10. In these mice, whole airway and EC HIF-2α protein expression was significantly reduced ( Figure XIII 
Endothelial HIF-2α Overexpression in Airway Donors Protects Allogeneic Microvasculature and Attenuates Inflammation During Transplant Rejection
Given the vasoprotective characteristics of endothelial HIF-2α, we questioned whether EC-specific overexpression of HIF-2α in donor airways could ameliorate rejection-mediated vascular injury. Hif-2α ECOE transplants displayed improved microvascular perfusion and diminished vascular leakage ( Figure 7D through 7H) . We hypothesized that increased HIF-2α might diminish vascular permeability by augmenting endothelial p-TIE2 expression. 28 After transplantation, Hif-2α ECOE transplants displayed significantly higher levels of p-TIE2 ( Figure 7I and 7J). Correspondingly, NG-2 + pericyte coverage was significantly enhanced in Hif-2α ECOE transplants ( Figure 7K and 7L) . Furthermore, Hif-2α overexpression diminished transplant EC apoptosis measured by activated caspase 3 ( Figure 7M and 7N) , consistent with HIF-2α's antiapoptotic function observed at baseline. Collectively, these findings suggest that endothelial HIF-2α augments vascular integrity during acute rejection by preserving pericytes and limiting apoptosis. Because such protection might be related to the immunomodulating effects of endothelial HIF-2α, we next investigated inflammation and adaptive immunity in these transgenic grafts.
Tracheas from Hif-2α ECOE donors showed significantly decreased expression of EC intercellular adhesion molecule 1 ( Figure 8A ), proinflammatory cytokines Il-1β, Il-6, and Mcp-1 ( Figure 8B ), and transplant rejection-related chemokines Cxcl-9 and Cxcl-10 29 ( Figure 8C ). Hif-2α ECOE allografts had dramatically decreased infiltrating CD4 + cells, CD8 + cells, macrophages, and neutrophils as determined by immunofluorescence (Figure 8, D-K) . Whole tracheal donor overexpression of Hif-2α or Dll4 or systemic Angpt1 overexpression via adenoviral gene therapy also preserved the microvasculature, including Hif-2α ECKO transplants ( Figure XVI in the online-only Data Supplement). These results indicate that exogenously augmenting HIF-2α may bolster vascular protection in airways undergoing acute rejection.
DISCUSSION
In this study, we demonstrated that EC HIF-2α, but not HIF-1α, is required to maintain airway microvascular structure and function. HIF-1α is most active with se- 
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vere hypoxia whereas HIF-2α may be more operational under physiologically hypoxic conditions. 30 In healthy airways not subjected to severe hypoxia, tonic HIF-2α signaling appears to be more crucial than that provided by HIF-1α, and our data may also explain why reduced EC Hif-2α causes abnormal lung vascular development. 31 In disease states, such as lung transplant rejection, our results also show that EC Hif-2α rather than EC Hif-1α may be a critical defense in the face of vascular injury. For these reasons, HIF-2α has potential to be a useful therapeutic target for certain lung conditions.
Tracheas lacking endothelial Hif-2α demonstrated airway epithelial layer disruption and tissue fibrosis. The epithelial loss was striking in airways where microvascular loss was most significant, a finding likely attributable to inadequate oxygen and nutrition delivery as well as reduced angiocrine factors that support epithelial structures. 32 Our previous study showed that tissue fibrosis ensues if an airway undergoes prolonged ischemia induced by alloimmune responses, 15 and the current data show that, even in the absence of inflammation, airway microvascular damage can cause fibrotic remodeling.
Airways lacking intimal Hif-2α exhibited compromised blood perfusion, augmented vascular leakage, and diminished pericyte coverage accompanied by the disrupted layout of the basement membrane. HIF-2α was required to maintain a healthy pulmonary vascular bed in adult mice and is consistent with the known functional roles of HIF-2α during embryonic development. 31 While ANGPT1-TIE2, ANGPT2-TIE2, and VEG- ECOE airways as donors (n=5). E and F, BPU measurements (E) and perfused area assessment (F) of the WT or Hif-2α ECOE airway transplants (n=5). G, Representative overlay confocal images of FITC-lectin perfusion (green) and microsphere permeability (red) analysis of the day 6 transplants using either WT or Hif-2α ECOE airways as donors (n=5). H, Quantification of microsphere intensity comparing the groups in G (n=5). I and J, Representative immunofluorescence staining of p-TIE2 (green) and CD31 (red) in day 6 transplants using either WT or Hif-2α ECOE airways as donors (I) and quantification of the p-TIE2 intensity (J) (n=6). K and L, Representative immunofluorescence staining of NG-2 (green) and CD31 (red) of the day 6 transplants using either WT or Hif-2α ECOE airways as donors (K) and quantification of the NG-2 intensity (L) (n=6). M and N, Representative immunofluorescence staining of activated Caspase 3 (green) and CD31 (red) of the day 6 transplant using either WT or Hif-2α 
FA-VEGFR2 signaling pathways were all dysregulated, only Angpt1 gene therapy prevented the vascular abnormalities associated with EC Hif-2α deficiency. Angpt2 or Vegfa gene therapies may fail to correct vascular disease in these transgenic airways because these angiogenic factors also promote vascular leakage and instability. 33, 34 Our in vitro findings suggest that the absence of HIF-2α-regulated TIE2 expression may explain why the TIE2/ p-TIE2 level is reduced in airways with Hif-2α ECKO. Tie2 is likely a direct HIF-2 target gene in pulmonary ECs given that HIF-2 induces a Tie2 promoter-driven reporter. 35 Previous studies have established that TIE2 is preferentially expressed in phalanx ECs of stabilized vessels, 36 and Tie2 deficiency induces pericyte loss and vascular instability. 21 Temporally, decreased TIE2 expression preceded the loss of pericytes in the transgenic tracheal microvasculature and suggests a causal relationship between diminished TIE2 signaling and vascular pathology. As pericytes are the primary producers of ANGPT1, reduced whole-tracheal ANGPT1 may have been due to the general diminution of airway pericytes in HIF-2α mice. 21 AdAngpt1 was able to improve vascular structure and function when ECs express a relatively low level of TIE2, which is consistent with a prior report in which ANGPT1 overexpression improved smooth muscle cell coverage of the myocardial microvasculature in diabetic mice subjected to myocardial ischemia. 37 In a 
different receptor-ligand system, VEGFC overexpression promoted the growth of functional lymphatic vessels in VEGFR3 (the receptor for VEGFC) heterozygous mice. 38 Our data support the notion that the ANGPT1/TIE2 signaling is essential for pulmonary vascular health. Tie2 heterozygous mice develop spontaneously increased right ventricular systolic pressure that is exacerbated by exposure to clinically relevant PH triggers such as serotonin or interleukin 6, and ANGPT1 treatment blunts the effect of serotonin on pulmonary hemodynamics. 39 This adverse effect of impaired ANGPT1/TIE2 signaling on the pulmonary vasculature is consistent with the finding that embryonic HIF-2α deficiency promotes PH in mice. 31 Interestingly, another study showed increased ANGPT1/TIE2 signaling in pulmonary ECs from idiopathic PH patients; increased pulmonary EC ANGPT1/ TIE2 signaling was linked to the enhanced pulmonary smooth muscle cell proliferation. 40 These findings collectively suggest that physiological levels of endothelial TIE2 activity are required for pulmonary microvascular health; low EC TIE2 activity predisposes the lung to PH, and aberrantly high EC TIE2 activity may play a role in sustaining the excessive growth of the perivascular smooth muscle cells and maintain vascular muscularization. Determining whether increased EC TIE2 activity in idiopathic PH lung results from HIF-2α dysregulation is an exciting direction for future investigation.
Building on prior findings that HIF-2α and ANGPT1 both induce Notch signaling, and that combined deficiency of Notch 1 and 3 causes pericyte loss, 24, 25, 41 we investigated endothelial Notch signaling in airway microvasculature and sought to elucidate the relationship between HIF-2α, ANGPT1/TIE2, and Notch activity in maintaining the normal airway microvasculature. In vivo, we found that Hif-2α ECKO airways displayed diminished expression of Notch target genes Efnb2, Hes1, Hes5, and Dll4, whereas ANGPT1 restored Notch target gene expression. Interestingly, EC Efnb2 expression is crucial for angiogenic remodeling during maturation of the vascular network. 42 Further, the angiogenic phenotype of the Efnb2 mutation is similar to that of Tie2 43 or Angpt1 mutations. 44 Hes1 and Hes5 are also involved in vascular remodeling as shown during brain development. 45 Although it is not known how precisely Efnb2, Hes1, or Hes5 may regulate airway microvascular development or maintenance, our data suggest that these genes are playing roles in stabilizing the airway vascular bed and that they are regulated by EC HIF-2α and tissue ANGPT1 expression. Direct Notch reactivation through DLL4 overexpression improved vascular function in Hif-2α ECKO airways. Furthermore, Rbpj ECKO mice also displayed microvascular abnormalities including decreased blood perfusion, increased vascular leakage, and a loss of pericytes, which phenocopied the key microvascular defects of Hif-2α ECKO mice. Accordingly, HIF-2α induction of Notch signaling was necessary for the maintenance of the normal airway microvasculature. Neither HIF-2α nor ANGPT1 was able to improve the microvasculature of Rbpj ECKO airways, further indicating that HIF-2α and ANGPT1 act as upstream activators of RBPJ-mediated transcriptional activation of Notch targets.
HIF-2α activated EC Notch signaling in a TIE2-dependent manner. HIF-2α production by ECs helps sustain the surface expression of endothelial TIE2 receptors, which, in turn, are continuously activated by pericyteproduced ANGPT1. Under homeostatic conditions, TIE2 activation is sufficient to maintain EC survival with basal Notch activity, EC-pericyte interactions, and vascular integrity. By contrast, EC HIF-2α deficiency decreases TIE2 expression. Events that cascade from this include EC apoptosis, diminished Notch signaling, pericyte loss, and loss of pericyte-derived ANGPT1, which further diminishes TIE2 signaling. In summary, airway microvascular anomalies following endothelial Hif-2α deletion include pericyte coverage loss, EC denudation, EC acquisition of excessive filopodia, and uneven surfaces of the vascular lumen (modeled in Figure 6J ).
To further characterize the role of endothelial HIF-2α beyond homeostatic conditions, we used the orthotopic tracheal allograft model in which microvascular disease causes irreversible airway pathology. 27 We previously showed that during the acute rejection phase, airway transplants are hypoxic, evidenced by decreased tissue Po 2 readings, 27 and increased tissue HIF-1α expression. 15 By distinction, we found decreased HIF-2α expression in rejecting tracheas, at the level of whole airway as well as endothelium. Th1-type cytokines suppress HIF-2α expression in myeloid cells. 46 In airway transplants, the alloimmune response to an major histocompatibility complex-incompatible airway induces Th1-dominant tissue inflammation that may have driven down HIF-2α expression. Consistent with the distinct role of HIF-α isoforms in physiological conditions, genetic deletion of endothelial HIF-2α, but not HIF-1α, accelerated transplant microvascular destruction.
In rejecting airways, genetically overexpressing endothelial HIF-2α preserved perfusion, augmented intimal p-TIE2, conserved pericyte coverage, and limited vascular permeability. These tracheas demonstrated lowered mRNA transcription of proinflammatory molecules that are associated with transplant rejection, including intercellular adhesion molecule 1, Il-1β, Il-6, Mcp-1, Cxcl-9, and Cxcl-10. This decline in inflammatory mediators coincided with diminished immune cell infiltration in HIF-2α-augmented transplants. The ANGPT1/TIE2 signaling is well known to limit tissue inflammation. 47 ANGPT1-induced TIE2 suppresses mycoplasma pulmonis-induced airway inflammation. 28 HIF-2α may therefore reduce transplant tissue inflammation through endothelial TIE2 activation. HIF-2α-induced TIE2 activity may suppress inflammation by directly enhancing pericyte coverage 48 It is possible that HIF-2α may also increase the transplant microvascular barrier function and limit tissue inflammation through VE-cadherin stabilization. 23 However, given the aforementioned study 48 suggesting that TIE2 activity can override the function of VE-cadherin-mediated vascular barrier integrity, HIF-2α-mediated VE-cadherin stabilization may be secondary to improving the airway microvascular barrier function. In summary, EC HIF-2α overexpression may improve transplant microvascular health by limiting tissue inflammation and EC apoptosis by activating the TIE2 signaling (modeled in Figure 8L ). Future efforts will be directed toward determining how HIF-2α/TIE2 downstream effectors suppress inflammation.
Although the normal expression level of endothelial HIF-2α is needed to protect the pulmonary microvasculature and prevent pulmonary vascular remodeling, 31, 39 HIFα subunits at the organism level appear to promote PH pathogenesis. 5, 6 It is intriguing to note that recent studies suggest that forced endothelial HIF-2α overexpression can promote PH through enhancing EC production of CXCL12 and elevating smooth muscle cell proliferation 8 or through suppressing EC expression of the apelin receptor and increasing vascular tone. 9 HIF-2α may also promote PH through upregulating arginase 1 and disrupting nitric oxide homeostasis. 7 Although these previous studies provided important insights into the role of EC HIF-2α in PH pathogenesis, the developmental impact of HIF-2α loss or overexpression also may have contributed to the adult pathology in these experiments because the Cre systems used were not estrogen receptor-controlled. By contrast, our model system provides unique insights into the role of endothelial HIF-2α in adult microvascular homeostasis because this gene was deleted from ECs after the animal was fully developed.
The current study has several limitations. Although we establish that the loss of endothelial HIF-2α in mice is associated with epithelial pathology and fibrosis, we do not know whether these changes were primarily attributable to the loss of the gene and its downstream products or, instead, to decreased microvascular perfusion (ie, any cause of ischemia could result in the same pathology). Although there were no overt vascular anomalies in the other evaluated organs (retina, heart, and kidney), it remains possible that subtle changes were present in these structures, which could also merit investigation. Further, it will be interesting to learn why airway endothelium, specifically, has a reliance on tonic HIF-2α signaling. Perhaps the most significant open questions concerning the specific roles played by endothelial HIF-2α are in the lower airways, lung parenchyma, and pulmonary vasculature. Bronchiolitis obliterans syndrome is a condition that primarily affects the terminal bronchioles, and acute rejection could similarly drive down HIF-2α levels with possible microvascular, epithelial, and fibrotic effects. Additionally, the restrictive allograft syndrome, another fibrotic manifestation of chronic rejection, could be driven by microvascular changes and influenced by HIF-2α expression. In chronic obstructive pulmonary disease, studies indicate lower HIFα activity 12, 13 and endothelial dysfunction, 49 and it will be interesting to determine whether endothelial HIFα subunits regulate disease pathogenesis. VEGFA levels are often low in emphysema lungs. 50 How endothelial HIF-2α may regulate VEGFA to affect chronic obstructive pulmonary disease pathogenesis remains an open question.
CONCLUSIONS
In summary, we found that endothelial HIF-2α is essential for normal airway microvascular structure and function. We also demonstrated, in a transplant model, that HIF-2α dampens tissue inflammation and promotes endothelial survival. Targeting endothelial HIF-2α could be useful as a treatment adjunct to high-dose steroids during acute rejection to prevent chronic rejection in patients undergoing lung transplantation. Our findings may be relevant for other solid organ transplants characterized by the loss and remodeling of the microvascular circulation, 1 as well as for other pulmonary diseases, such as chronic obstructive pulmonary disease and PH, also defined by vascular compromise. 
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